Effects of atrioventricular asynchrony on platelet activation: Implication of thromboembolism in paced patients

Heart

Volumn 78, Issue 4, 1997, Pages 358-363

  Lau, Chu Pak ^a   Tse, Hung Fat ^a   Cheng, Gregory ^b  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b Department of Pathology ^*

Author keywords

Pacing; Platelet activation; Thromboembolism

Indexed keywords

THROMBOCYTE FACTOR 4;

ARTICLE; CLINICAL ARTICLE; HEART BLOCK; HEART PACING; HEART RATE; HOLTER MONITORING; HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SICK SINUS SYNDROME; THROMBOCYTE ACTIVATION; THROMBOEMBOLISM; THROMBOGENESIS;

EID: 0030690047     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.78.4.358     Document Type: Article

References (32)

1. Furman S, Robinson G. The use of an intracardiac pacemaker in the correction of total heart block. Surg Forum 1958;9:245.
2. Kaul T, Kumar EB, Thomson RM, Bain WH. Sinoatrial disorder; "the sick sinus" syndrome. Experience with implanted cardiac pacemaker. J Cardiovasc Surg 1978;19: 261-6.
3. Breivik K, Ohm OJ, Segadal L. Sick sinus syndrome treated with permanent pacemaker in 109 patients. Acta Med Scand 1979;206:153-9.
4. Stone JM, Bhakta RD, Lutgen J. Dual chamber sequential pacing management of sinus node dysfunction: advantage over single chamber pacing. Am Heart J 1982;104:1319-27.
5. Sutton R, Kenny RA. The natural history of sick sinus syndrome. Pacing Clin Electrophysiol 1986;9:1110-14.
6. Rosenqvist M, Brandt J, Schuller H. Long-term pacing in sinus node disease: effects of stimulation mode on cardiovascular morbidity and mortality. Am Heart J 1988;116:16-22.
7. Langenfeld H, Grimm W, Maisch B, Kochsiek K. Atrial fibrillation and embolic complications in paced patients. Pacing Clin Electrophysiol 1988;11:1667-72.
8. Hesselson AB, Parsonnet V, Bernstein AD, Bonavita GJ. Deleterious effects of long term single chamber ventricular pacing in patients with sick sinus syndrome: the hidden benefits of dual chamber pacing. J Am Coll Cardiol 1992;19:1542-9.
9. Sgarboss EB, Pinski SL, Maloney JD, Simmons TW, Wilkoff BL, Castle LW, et al. Chronic atrial fibrillation and stroke in paced patients with sick sinus syndrome: relevance of clinical characteristics and pacing modalities. Circulation 1993;88:1045-53.
10. Andersen HR, Thuesen L, Bagger JP, Vesterlund T, Thomsen PEB. Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome. Lancet 1994;344: 1523-8.
11. Levine PH, Fisher M, Fullerton AL, Duffy CP, Hoogasian JJ. Human platelet factor IV: preparation from outdated platelet concentrates and application in cerebral vascular disease. Am J Hematol 1981;10:375-85.
12. Stewart ME, Douglas JT, Lowe GD, Prentice CR, Forbes CD. Prognostic value of beta-thromboglobulin in patients with transient cerebral ischemia. Lancet 1983;ii:479-82.
13. Patrono C. Aspirin as an anti-platelet drug. N Engl J Med 1994;330:1287-94.
14. Files J, Malpass T, Yee E, Ritchie J, Harker L. Studies of human platelet alpha granule release in vivo. Blood 1981;58:607-18.
15. Wu KK. Platelet activation mechanisms and markers in arterial thrombosis. J Intern Med 1996;239:17-34.
16. Kaplan KL, Owen J. Plasma levels of β-thromboglobulin and platelet factors 4 as indices of platelet activation in vivo. Blood 1981;57:199-202.
17. Kaplan KL. Laboratory marker of platelet activation. In: Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Hemostasis and thrombosis: basic principles and clinical practice, 3rd ed. Philadelphia: Lippincott, 1994:1180-1.
18. Sutton R, Markowitz T. Toward physiological stimulation in sinus node disease. Eur J Cardiac Pacing Electrophysiol 1994;2:126-31.
19. Fazio S, Cittadini A, Sabatini D, Santomauro M, Cocozza M, Oliviero U, et al. Platelet aggregability in patients with a VVI pacemaker. Pacing Clin Electrophysiol 1993;16:254-6.
20. Fazio S, Santomauro M, Cittadini A, Ferraro S, Lucariello A, Maddalena G, et al. Efficacy of ticlopidine in the prevention of thromboembolic events in patients with VVI pacemaker. Pacing Clin Electrophysiol 1991;14:168-73.
21. Wu KK, Hoak JC. A new method for quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet 1974;ii:924-6.
22. Mehta P, Mehta J. Platelet function studies in coronary artery disease. V. Evidence of enhanced platelet micro thrombus formation activity in acute myocardial infarction. Am J Cardiol 1977;43:757-60.
23. Dougherty JH, Levy DE, Weeksler BB. Platelet activation in acute cerebral ischaemia. Lancet 1977;i:821-4.
24. Shah AB, Beamer N, Coull BM. Enhanced in-vivo platelet activation in subtypes of ischemic stroke. Stroke 1985;16: 643-7.
25. Sally N, Dugdale M. Platelet abnormalities in ischemic heart disease. Am J Cardiol 1973;32:612-8.
26. Rasi V, Ikkala E, Torstila I. Plasma β-thromboglobulin in acute myocardial infarction. Thromb Res 1982;25:203-12.
27. FitzGerald DJ, Rey L, Catella F, FitzGerald GA. Platelet activation in unstable coronary disease. N Engl J Med 1986;313:1194-210.
28. Trip MD, Cats VM, van Capelle FJ, Vreeken J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med 1990;323:1549-54.
29. Ghaddar HB, Cortes J, Saloma V, Kark JD, Davis CE, Folson AR, et al. Correlation of specific platelet activation markers with carotid artery wall thickness. Thromb Haemost 1995;74:943-8.
30. Antiplatelet Trialists' Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet therapy. BMJ 1988;296:320-31.
31. Yamauchi K, Furui H, Taniguchi N, Sotobata I. Plasma β-thromboglobulin and platelet factor 4 concentration in patients with atrial fibrillation. Jpn Heart J 1986;27:481-7.
32. Lau CP, Tai YT, Leung WH, Wong CK, Lee P, Chung LW. Rate adaptive pacing in sick sinus syndrome: effects of pacing modes and intrinsic conduction on physiological responses, arrhythmias, symptomatology and quality of life. Eur Heart J 1994;15:1445-55.